Genmark Diagnostics (GNMK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Sales | 20,918 | 18,374 | 21,533 | 19,378 | 15,795 |
| Cost of Goods | 13,868 | 11,801 | 15,670 | 14,106 | 10,165 |
| Gross Profit | 7,050 | 6,573 | 5,863 | 5,272 | 5,630 |
| Operating Expenses | 18,206 | 19,284 | 17,443 | 15,990 | 16,363 |
| Operating Income | -10,288 | -11,910 | -10,910 | -10,612 | -10,568 |
| Interest Expense | 1,527 | 1,528 | 1,276 | 862 | 661 |
| Other Income | 107 | 175 | 122 | -9 | 241 |
| Pre-tax Income | -11,708 | -13,263 | -12,064 | -11,483 | -10,988 |
| Income Tax | -33 | 45 | 16 | 80 | 5 |
| Net Income Continuous | -11,675 | -13,308 | -12,080 | -11,563 | -10,993 |
| Net Income | $-11,675 | $-13,308 | $-12,080 | $-11,563 | $-10,993 |
| EPS Basic Total Ops | -0.20 | -0.23 | -0.21 | -0.20 | -0.20 |
| EPS Basic Continuous Ops | -0.20 | -0.23 | -0.21 | -0.21 | -0.20 |
| EPS Diluted Total Ops | -0.20 | -0.23 | -0.21 | -0.20 | -0.20 |
| EPS Diluted Continuous Ops | -0.20 | -0.23 | -0.21 | -0.21 | -0.20 |
| EPS Diluted Before Non-Recurring Items | -0.20 | -0.23 | N/A | N/A | N/A |
| EBITDA(a) | $-8,097 | $-9,733 | $-8,753 | $-8,624 | $-8,684 |